What life can do Abolis Biotechnologies is a French biotechnology company specializing in microbial systems and industrial-grade biotech applications for the food, cosmetics, healthcare and chemical industries. The company helps innovators, manufacturers and R&D teams understand complex microbial systems and address critical industrial challenges through ingredient and biotics development, process optimisation and product innovation. Combining expertise in strain engineering, microbial metabolism, fermentation and bioprocess development with proprietary technologies and an integrated industrial approach, Abolis supports projects from early discovery through to scale-up readiness and industrial application. Synthetic Biology, Metabolic engineering, Pathway engineering, Molecular biology, Fine chemicals, Performance chemicals, Bioinformatics, nutrition, …

143 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

More sustainable, ethical, animal-free heparin alternative Developing an animal-free heparin alternative from bio-based secondary feedstocks. Biotechnology, Pharmaceuticals, R&D, Fermentation, Glycosaminoglycans, and Heparin

68 similar entities Type: Startup Activities: biotech deeptech Technologies: Decarbonization

Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation.

165 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutics to improve outcomes in conditions with unmet medical needs. Our offices and laboratory are located in San Carlos, CA. Microbial Therapeutics, Host Microbe Interactions, Human Microbiome, and Pharmaceutical Development

271 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis

122 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

To be the Global Leader in Testing for Life. The Eurofins network of laboratories in Malaysia contributes to a safer and healthier world by providing laboratory testing, monitoring and advisory services across key sectors, including food and feed, environment, consumer products and occupational health and safety. The Eurofins network’s presence in Malaysia comprises 8 laboratories across key locations in the Penang, Johor, and Central regions, and combines local expertise with access to a global infrastructure of state-of-the-art testing facilities. With a focus on scientific excellence and regulatory compliance, Eurofins laboratories In Malaysia employ over 300 people and perform advanced chemical, …

56 similar entities Type: SMB Activities: biotech deeptech

We incubate, fund, and launch new companies that use programmed biology to shape the human future. Ferment is a venture studio building new companies that rapidly translate biology into products that solve targeted problems across industrial and consumer markets including food & nutrition, industrials & waste, materials, consumer health and more. synbio, synthetic biology, biotech, programmed biology, venture studio, company creation studio, incubator, venture capital, biotechnology, industrial biotechnology, and consumer biotechnology

73 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Expert in microorganism detection & enumeration in the environment C4Hydro is a biotechnology company based out of GRAND LUMINY TECHNOPOLE ZONE LUMINY 163 AVENUE DE LUMINY, MARSEILLE CEDEX 09, France. Biotechnologies, Bactériologie, Légionelle, Legionella pneumophila, Environnement, and Microorganismes

55 similar entities Type: Startup Activities: biotech deeptech cleantech greentech

Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica

79 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Biotech Company 100% Focused on Pediatric Cancer Drug Development A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer

170 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a wholly owned subsidiary of Pharmacosmos. Cancer / Oncology, Drug Discovery and Development, and Biotechnology

140 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We accompany companies with a complete service of Preclinical Trials and Clinical Trials of safety and efficacy GOYA INNOVA is a Spanish laboratory with 50 years of experience, specialized in preclinical and clinical evaluations of safety and efficacy for cosmetic, health products and food supplements.⁣ We manage 55,000 samples annually, and with our partners, we offer a comprehensive service.⁣ Our differential model of preclinical and clinical research integrates a CRO with its own Medical and Medical-Aesthetic Center.⁣ With more than 40 doctors of different specialties, we can:⁣ • Carry out studies under the highest quality standards⁣ • Optimize costs and …

289 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Developing Breakthrough Cancer Immunotherapies Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile. Cancer Immunotherapies, Phosphatases, Immuno-Oncology, Checkpoint inhibitors, CAR-T, and Solid tumours and Lymphomas

344 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances brain delivery technology to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in Stevenage, UK.

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

INRAE research unit - Environmental biorefinery Laboratoire de Biotechnologie de l'Environnement - Unité propre de recherche de l'INRA Biotechnology, Process engineering, Modelisation, and Microbial ecology

73 similar entities Type: Startup Activities: biotech deeptech

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

359 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal

180 similar entities Type: SMB Activities: biotech healthtech Technologies: Synthetic Biology

Animal Health Innovation Based in France, we are an independent veterinary laboratory, expert in 3 fields: - Vaccine adjuvants for all livestock, - Diagnostic solutions for aquaculture, - Contract research and services in aquaculture health (CRO and CMO). Animal health, Adjuvant, Veterinary Adjuvant, CRO, Aquatic animal health, Tilapia, Veterinary diagnostic, Diagnostic, Aquaculture, Vaccine development, R&D, and GMP

117 similar entities Type: Startup Activities: pettech healthtech deeptech Technologies: Synthetic Biology

We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing

227 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is …

224 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I.

Nano Drug Solutions Revolutionizing neuropathy treatment Development of innovative nanomedicines targeting neuropathies, with a particular focus on hereditary neuropathies such as Charcot-Marie-Tooth disease Biothechnology

150 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

“Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care

278 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Laboratory Testing Excellence Eurofins Biolab S.r.l. is a GMP & GLP Laboratory part of the BioPharma Product Testing Division of Eurofins Scientific. Pharmaceuticals, Medical Devices, Biocides and Cosmetics are our main areas of interest GMP, GLP, ISO 17025, ISO 9001, ISO 13485, ISO 22716, FDA INSPECTED, BioPharmaceutical Testing, Medical Device Testing, Biocide Testing, Cosmetic Testing, Professional Scientific Services, Regulatory and Consultancy, Microbiological and Chemical Testing, Training, and Laboratory Testing

244 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Arkaïya is a groundbreaking platform developing archaea diagnostics and therapeutics for human health and disease. Archaea strains associated with mother’s milk that promote healthy immune system development

63 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and …

46 similar entities Type: Startup Activities: healthtech biotech deeptech

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

349 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

519 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune

565 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Genenta Science (Nasdaq: GNTA), which will be renamed as Saentra Forge (Nasdaq: SAEN) About: Genenta Science (Nasdaq: GNTA), which will be renamed as Saentra Forge (Nasdaq: SAEN, pending effectiveness), will be a next-generation strategic consolidator focused on privately held specialized companies operating in Italian national security regulated sectors, with activities spanning cybersecurity, defense, aerospace, and biotechnology/biosecurity. Defence, Cybersecurity, Aerospace, and National Security

90 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

297 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Advancing what’s next in nutrition De Novo Foodlabs is a pioneering biotech start-up revolutionising the field of nutrition. Leveraging the power of microbial fermentation, the company creates innovative products that promote better health for both people and the planet. Food design, Product Development, Recombinant proteins, nutrition, health, and alternativeproteins

188 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

A subsidiary of Corning Inc. Founded and incorporated in 1993, Axygen Scientific is the leading global supplier of laboratory plastics for the research industry, including the pharmaceutical, biotech, and academia markets. Axygen, Inc. is now a part of Corning Incorporated. laboratory plastics, research, pharmaceutical, biotech, and academia

53 similar entities Type: SMB Activities: biotech deeptech

Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors.

107 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Curileum is intervening early in serious gastrointestinal (GI) disease development with novel diagnostics & therapeutics Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa Biotechnology

143 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

310 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

514 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Galactica Biotech applies AI methods to identify new applications for molecules, expanding the IP portfolio of companies in multiple areas. Molecule characterization, Novel compound applications, and Pesticides

135 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine

348 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Neem’s Hill is a holding company focused on investments and innovations in the medical device sector. Through its portfolio companies, it develops and commercializes patented Tumour Specific Electroporation (TSE) technology for cancer treatment. Today, the Group operates in both Human Care and Animal Care, with the ambition to improve clinical outcomes while reducing side effects through innovative, tissue-preserving cancer treatments. Cancer Treatments, Research, Clinical Development, Chemotherapy, and Immunotherapy

307 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl. Originating as a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology, the cell technology company aims to fill therapeutic gaps for the many still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer With its team of leading cell therapy experts, Evotec (Moderna) adds a high-quality cGMP manufacturing site to the EVOcells platform increasing capacity, critical expertise, and capabilities …

160 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Casting light on the microbiome We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life. microbiome, precision medicine, biotechnology, diagnostics, immuno-oncology, and companion diagnostics

221 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception. medical device, biotechnology, urology, contraception, womenshealth, reproductivehealth, and menshealth

252 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

535 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance

419 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery

561 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

Cultivating the next generation of animal products. PARIMA is a global leader in next-generation animal production, pioneering a more sustainable and efficient way to create high-quality animal products through innovation. Formed from the combination of Gourmey and Vital Meat, the company builds on deep expertise in cell cultivation, bioprocessing, and food science. PARIMA develops real animal products directly from cells across multiple species, combining advanced technology with culinary excellence at its headquarters in France. PARIMA’s culinary brand, Gourmey, focuses on premium cultivated proteins developed in collaboration with leading Michelin-starred chefs worldwide.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The leading international supplier to the microbiology and tissue culture industries Don Whitley Scientific is a leading international supplier of innovative equipment and services to the microbiology and tissue culture industries. We develop, manufacture, market and service instrumentation and associated products for the public and private sector - primarily for use in hospitals, public health laboratories, food testing organisations and research institutions. We now have the largest, most comprehensive range of workstations specifically designed for the study of anaerobes and microaerophiles. Automated microbiology and cell culture equipment, Contract microbiology laboratory, and Service and maintenance contracts

149 similar entities Type: SMB Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Delivering local-acting immunotherapies to patients ATMP, Gene Therapy, Drug development, Clinical trials, GMP, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, IBD, Cysticfibrosis, SAVI, colitis, Cystic fibrosis, and Inhalation

646 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

New therapeutic targets based on arsenic trioxide (As2O3) Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. santé, biotechnologies, bioparma, biopharmaceutical, biotech, health, biotechnology, autoimmune diseases, and maladies auto-immunes

259 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Make with Biology Amino Labs' mission is to make biotechnology learning and innovation accessible to teenagers, educators, and adults. Youtube: https://www.youtube.com/c/AminoLabs Education, Genetic Engineering, STEM, Hands-on Experiments, Zero to Genetic Engineering Hero, biology kits, STEAM, and science education

114 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology

Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules

370 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering Precision Biocontrols Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODYTM technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from …

257 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Providing laboratory and microbiological equipment and supplies for 30 years. Trafalgar Scientific was established in 1993 by Matthew Bramley with the intention of selling 3M Petrifilm, an as then unknown product aimed at the food microbiology market. Following the success of the sale of 3M Petrifilm, today Trafalgar Scientific has the luxury of working with some of the biggest names in the food and beverage services industry and third party laboratories in the UK. Our main business has stayed with the supply of unconventional, niche products and with the continual addition of more conventional microbiology products to our range, Trafalgar …

48 similar entities Type: SMB Activities: biotech deeptech

business development mission in Life Sciences IVD Cosmetic finding new customers finding new partners BtoBioInnovation offers outsourced services in Marketing & Business Development in Life Sciences, Biotech, Molecular Diagnostics, Cosmetic, Nutraceutical : - Operational Marketing : representation on Trade shows, congresses, Seminar organisation - E-Marketing: E-mailing Campaign, Google Analytics, webinars - Strategic Business Development: Chinese Market, Trends in oncology, Neurology, Biomarkers, Molecular Diagnostics, coaching for Negociation & Due Diligence, Analysis of Pharma & Biomedical Industries. - Operational Business Development: Identify & qualify new customers, partners, distributors, Sourcing licensing opportunities, Marketing, Business development, Biotech, Life sciences, In vitro diagnostics, Cosmetic, Nutraceutical, …

222 similar entities Type: SMB Activities: martech biotech Technologies: Synthetic Biology

Discovering from green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with properties of high added value (of interest to the consumer, farmers and the agri-food industry) and more resistant to stress, as well as less dependent on chemical treatments, in order to contribute to less aggressive agriculture with the environment. - Advanced services in Genomics, Proteomics, Metabolomics, Bioinformatics, Microscopy, Plant Hormone Quantification, DNA Sequencing and Gene Expression Analysis. - Training of research personnel. Biotechnology, Molecular Biology, Genomics, Proteomics, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology

182 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Breeding Varroa resistant honey bees to eliminate bee hive collapse. Arista Bee Research is a foundation based in the Netherlands with sister foundations in Belgium and the United States (Dallas, Texas).

24 similar entities Type: Startup Activities: deeptech

Ensure sustainability and produce more with less. We believe that making the world a better place is possible by uniting talented people with innovative companies. Thus, we have developed a complete and unique experience in the biological market, capable of providing equipment, inputs and technical assistance in an integrated manner so that rural producers can produce their own bio-inputs on the farm with quality, profitability and agronomic efficiency. Bioinputs, OnFarm Biological Management, Biotechnology, and OnFarm Bioinputs

244 similar entities Type: Startup Activities: deeptech Technologies: Bio sourced materials

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

582 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Developing technology for tomorrow's crops AgGene is an agriculture biotechnology company focused on the development of plant traits to address major challenges faced during crop production. Our flagship technology addresses the demand for improving protein content in plant tissues using advanced genomics and molecular plant breeding techniques including gene-editing. AgGene is also focused on collaborative relationships with other agriculture companies and independent plant breeders to help develop plant biotech traits to address issues including climate resilience. biotechnology, gene editing, agriculture, molecular genetics, molecular biology, genomics, genetic engineering, and plant biology

66 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

The Uniqueness of Individualized Neoantigen Cancer Vaccine to Reshape the Future of Early-Stage Cancer Treatment Cancer immunotherapy Transgene (Euronext: TNG) is a clinical-stage biotechnology company focused on individualized therapeutic vaccines

166 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Oak Hill Bio's mission is to develop life-changing medicines for patients suffering from rare diseases Oak Hill Bio is a clinical-stage biotech company committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing

183 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing RNA's technologies Desarrollamos tecnologías basadas en ARNs con el fin de potenciar la productividad de los cultivos (principalmente intensivos) de manera respetuosa del ambiente y la salud humana. Se trata de una tecnología no transgénica que permite inmunizar a los cultivos contra patógenos específicos (hongos, insectos, virus), a modo de “vacuna”. Además, sabemos cómo modular el desarrollo del cultivo, su respuesta al ambiente o la acumulación de metabolitos de interés mediante el diseño de ARNs como moléculas bioactivas exógenas que modulen la expresión de genes de la planta. Acelerados por EIT FAN de la Unión Europea Fruits, Biotech, RNA, …

107 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerating Biologics Discovery with Advanced Cell Based Functional Assays, Yeast & Mammalian Display Platforms, Ranomics is a CRO partner in engineering better biologics, faster. With expertise in custom cell-based functional and screening assays, yeast display and mammalian display, we are a valuable parter in protein engineering, antibody engineering, antibody discovery and custom biologics development. Disease Prediction, Human Genetics, Genome Sequencing, biotechnology, synthetic biology, protein engineering, genomics, drug discovery, mutagenesis, gene synthesis, dna variant library, antibody, DNA, Protein, Research, Contract Research, Biotechnology, Catalysis, Bioprocess Engineering, Biologic Manufacturing, Biochemistry, and Epitope Mapping

207 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Berkeley Lights is now part of Bruker Cellular Analysis Berkeley Lights is now part of Bruker Cellular Analysis biotech, single cell, micro-fluidics, cancer genomics, human oncology, life science, optics, molecular biology, and oncology

117 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

LexaGene’s MiQLab® System— For BioPharma - Automated Bioburden Testing LexaGene Life Sciences is an early-stage company focused on servicing the biopharmaceutical industry by developing advanced microbial testing solutions. Bioburden Testing, Microbial Contamination Testing, and BioPharma Sterility Testing

143 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design

132 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Lontra Ventures is an Austin, Texas based entrepreneurial consultancy with two core specialties: Life Science Consulting: Specialty Drug Commercialization & Selling Value Added Services to Pharmaceutical Manufacturers Technology: Business Development & Strategic Sales for High-Growth Companies

64 similar entities Type: SMB Activities: biotech consulting Technologies: Synthetic Biology